Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Course of Alefacept in Psoriasis
NCT00168753Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2004
- Primary completion
- Mar 2005
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of alefacept in plaque psoriasis, sponsored by Astellas Pharma. Started Jul 2004; status: completed.
02
Drugs
alefacept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00168753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168753.